Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
Global Genes was honored to be invited by the FDA to participate in a closed roundtable discussion […]
Read moreCURE SYNGAP1 announces $111,960 investment in RARE-X partnership to advance ProMMIS patient-reported outcome measure data collection – PR46
CURE SYNGAP1 is proud to announce a strategic investment of $111,960 in RARE-X to accelerate the collection of high-quality […]
Read moreSavara’s Early Access Program
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]
Read morePublication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreIndustry News
FDA Green Lights Human Clinical Trial of BGTC Developed Gene Therapy for MSD
Rare Daily Staff The U.S. Food and Drug Administration has cleared the way for human clinical trials […]
Read moreUnited Therapeutics Expands Regen Med Platform with $300 Million Acquisition of Thymus Therapy
Rare Daily Staff United Therapeutics is deepening its push into regenerative medicine and immune system engineering with […]
Read moreFDA Approves Expaneded Use of Vertex’s SCD Gene Therapy
Rare Daily Staff The U.S. Food and Drug Administration has approved an expanded label for Vertex Pharmaceuticals […]
Read moreRewiring the Rare Disease Diagnostic Odyssey
Families seeking a diagnosis for a rare disease often face a protracted diagnostic odyssey that can include […]
Read moreIpsen Expands Rare Disease Portfolio with $797 Million Acquisition of Memo
Rare Daily Staff Paris-based Ipsen said it will acquire the Swiss biotech Memo Therapeutics in a deal […]
Read moreBioCryst to Scrap Internal Discovery
Rare Daily Staff BioCryst Pharmaceuticals is shutting down its internal drug discovery operations and closing its Birmingham, […]
Read moreGene Editing Therapy for Rare Immune Disorder Moves Closer to Clinic
Rare Daily Staff A first-in-class gene therapy targeting CTLA-4 insufficiency, a rare and debilitating immune disorder, is […]
Read moreFDA Approves Viridian’s TED Therapy
Rare Daily Staff The U.S. Food and Drug Administration has approved Viridian Therapeutics’ Lumvoa for thyroid eye […]
Read moreCIRM Issues $60 Million in Grants Including Funding for FOXG1 Gene Therapy
Rare Daily Staff California Institute of Regenerative Medicine, the state’s stem cell agency, is issuing $60 million […]
Read moreGenetic Counseling
RARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreGlobal Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreResearch Readiness
Scientists Develop New Gene Editing Approach Capable of Gene-Sized Insertions
Rare Daily Staff Scientists at UMass Chan Medical School have unveiled a new gene editing approach that […]
Read moreTiny Worms May Unlock New Treatments for Rare Childhood Disorder
Rare Daily Staff Researchers at Brown University have developed genetically engineered versions of C. elegans—tiny worms commonly used […]
Read moreGene Therapy Innovators Share 2026 Breakthrough Prize
Rare Daily Staff The Breakthrough Prize Foundation awarded the 2026 Breakthrough Prizes in Life Sciences to a […]
Read moreIllumina Partners with D3b to Advance Genomic Research in Pediatric Rare Diseases
Rare Daily Staff Illumina and the Center for Data-Driven Discovery in Biomedicine (D3b) have entered a partnership […]
Read moreUC Berkeley Partners with BioMarin to Accelerate Rare Disease Research
The UC Berkeley Molecular Therapeutics Initiative (MTI) has entered into a new research collaboration with BioMarin Pharmaceutical […]
Read moreOxford-Harrington Awards Nearly $900K in Friedreich’s Ataxia Grants
Rare Daily Staff The Oxford-Harrington Rare Disease Centre’s FA Alliance Innovation Fund has awarded funding to five […]
Read moreMental Health & Wellness
Global Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Daily
Ionis Enters Global Licensing Deal with Recordati for Alexander disease ASO
Rare Daily Staff Ionis Pharmaceuticals has struck a global licensing deal with Italy-based Recordati to bring its […]
Read moreEmerging from a Life in the Shadows
Erythropoietic protoporphyria (EPP) is a rare, inherited metabolic disorder that triggers a toxic photochemical reaction in skin […]
Read moreUniQure Raises $225 Million to Back Accelerated Approval Bid for Huntington’s Gene Therapy
Rare Daily Staff UniQure is capitalizing on an improved regulatory outlook for its experimental Huntington’s disease gene […]
Read moreSangamo Files for Bankruptcy, Lilly and Astellas Line up as Lead Bidders for Assets
Rare Daily Staff Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection and entered into asset sale […]
Read moreNura Raises $73.8 Million to Advance Novel ALS Strategy
Rare Daily Staff Nura Bio said it raised $73.8 million in series B financing and began clinical […]
Read moreFDA Reverses Course on Regenxbio’s MPS II Gene Therapy, Clearing Path to Possible Accelerated Approval
Rare Daily Staff Regenxbio said it has reached agreement with the U.S. Food and Drug Administration on […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List